BeStock  
Stocks › ARQT

Arcutis Biotherapeutics ARQT

US equityMarket cap rank #2441
$25.15 −$0.01 (-0.04%)
Pre-market · Oct 6, 7:40 am ET · After hours $25.25 +0.40%
Open$25.09
Prev close$25.16
Day range$24.69 – $25.39
Volume2.31M
Market cap$3.16B
P/E (TTM)114.3
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$129.86M+59.3% YoY
Operating profit$16.43M+212.4% YoY
Net profit$15.01M+194.5% YoY
Diluted EPS$0.11+184.6% YoY

Revenue, last 8 quarters

$44.8MSep '24$71.4MDec '24$65.8MMar '25$81.5MJun '25$99.2MSep '25$129.5MDec '25$105.4MMar '26$129.9MJun '26

Net profit, last 8 quarters

$-41.5MSep '24$-10.8MDec '24$-25.1MMar '25$-15.9MJun '25$7.4MSep '25$17.4MDec '25$-11.3MMar '26$15.0MJun '26

Diluted EPS by quarter

-0.33Sep '24-0.09Dec '24-0.20Mar '25-0.13Jun '250.06Sep '250.13Dec '25-0.09Mar '260.11Jun '26

Profitability & balance sheet

Gross margin90.2%
Operating margin-3.3%
Net margin-4.3%
Return on equity-9.3%
Return on assets-4.1%
Return on invested capital-4.8%
Current ratio3.17
Liabilities / assets54.8%
Cash & investments$238.55M
Total debt$114.14M
Net cash (debt)$124.42M

Where the revenue comes from

Quarter 2026/Q2

By business line

  • ZORYVE foam$67.38M 51.9%
  • ZORYVE cream 0.3%$35.33M 27.2%
  • ZORYVE cream 0.15%$24.23M 18.7%
  • ZORYVE cream 0.05%$2.93M 2.3%

Income statement

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Total Revenue as Reported $129.86M $105.40M $129.50M $99.22M $81.50M
Total Operating Revenue $129.86M $105.40M $129.50M $99.22M $81.50M
Cost of Revenue $10.94M $9.78M $11.69M $8.69M $7.49M
Gross Profit $118.92M $95.61M $117.82M $90.53M $74.01M
Operating Expense $102.49M $104.70M $99.43M $82.01M $88.62M
Selling and Admin Expenses $82.14M $74.08M $78.98M $62.40M $69.17M
Research & Development $20.36M $30.63M $20.45M $19.60M $19.45M
Operating Profit $16.43M -$9.09M $18.39M $8.53M -$14.61M
Net Non-Operating Interest Income (Expense) -$1.13M -$2.09M $5.90M -$3.07M -$953,000.00
Non-Operating Interest Income $2.28M $2.28M – – $2.08M
Non-Operating Interest Expense $3.41M $4.37M $3.00M $3.07M $3.03M
Other Income (Expense) -$157,000.00 -$20,000.00 -$6.42M $2.04M $20,000.00
Other Non-Operating Income (Expenses) -$157,000.00 -$20,000.00 -$6.42M $2.04M $20,000.00
Pretax Profit $15.15M -$11.20M $17.87M $7.49M -$15.54M
Tax $136,000.00 $93,000.00 $470,000.00 $80,000.00 $342,000.00
Net Profit $15.01M -$11.30M $17.40M $7.41M -$15.89M
Profit from Continuing Operations $15.01M -$11.30M $17.40M $7.41M -$15.89M
Net Income to Parent Company $15.01M -$11.30M $17.40M $7.41M -$15.89M
Net Income to Common Stockholders $15.01M -$11.30M $17.40M $7.41M -$15.89M
Basic EPS $0.11 -$0.09 $0.14 $0.06 -$0.13
Diluted EPS $0.11 -$0.09 $0.13 $0.06 -$0.13

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $488.54M $460.00M $432.97M $432.97M $370.98M
Total Current Assets $467.67M $438.06M $411.23M $411.23M $349.22M
Cash and Cash Equivalents & Short-Term Investments $238.55M $224.00M $220.98M $220.98M $191.07M
-Cash and Cash Equivalents $34.12M $34.76M $42.91M $42.91M $47.12M
-Short Term Investments $204.43M $189.24M $178.08M $178.08M $143.95M
Receivables $155.16M $144.38M $146.23M $146.23M $115.12M
-Accounts Receivable $155.16M $144.38M $146.23M $146.23M $115.12M
Prepaid Assets $19.56M $18.66M $12.06M $12.06M $10.92M
Inventory $38.88M $37.39M $22.63M $22.63M $22.42M
Restricted Cash $308,000.00 $308,000.00 $308,000.00 $308,000.00 $308,000.00
Other Current Assets $15.21M $13.32M $9.02M $9.02M $9.40M
Total Non-Current Assets $20.87M $21.95M $21.74M $21.74M $21.75M
Net PPE $5.13M $5.40M $5.51M $5.51M $5.78M
-Gross PPE $5.13M $5.40M $8.76M $8.76M $5.78M
Goodwill and Other Intangible Assets $13.69M $14.25M $14.81M $14.81M $15.38M
Other Non-Current Assets $2.05M $2.30M $1.42M $1.42M $596,000.00
Total Liabilities $267.96M $270.36M $243.49M $243.49M $212.90M
Total Current Liabilities $160.34M $163.20M $129.84M $129.84M $99.77M
Payables $6.60M $18.30M $12.53M $12.53M $5.80M
-Accounts Payable $6.60M $18.30M $12.53M $12.53M $5.80M
Current Accrued Expenses $131.28M $126.63M $95.78M $95.78M $74.67M
Short-Term Debt and Capital Lease Obligation $6.95M $7.95M $1.00M $1.00M $1.00M
-Current Debt $6.95M $7.95M $1.00M $1.00M $1.00M
Total Non-Current Liabilities $107.62M $107.15M $113.66M $113.66M $113.13M
Long Term Debt and Capital Lease Obligation $107.19M $106.72M $113.23M $113.23M $112.77M
-Long Term Debt $101.95M $101.47M $107.96M $107.96M $107.50M
-Long Term Capital Lease Obligation $5.24M $5.25M $5.27M $5.27M $5.28M
Other Non-Current Liabilities $431,000.00 $431,000.00 $431,000.00 $431,000.00 $360,000.00
Total Equity $220.58M $189.65M $189.48M $189.48M $158.07M
Stockholders' Equity $220.58M $189.65M $189.48M $189.48M $158.07M
Capital Stock $12,000.00 $12,000.00 $12,000.00 $12,000.00 $12,000.00
-Common Stock $12,000.00 $12,000.00 $12,000.00 $12,000.00 $12,000.00
Additional Paid-In Capital $1.36B $1.34B $1.33B $1.33B $1.31B
Retained Earnings -$1.13B -$1.15B -$1.14B -$1.14B -$1.16B
Gains/Losses Not Affecting Retained Earnings -$656,000.00 -$514,000.00 -$44,000.00 -$44,000.00 -$62,000.00
-Accumulated Depreciation – – -$3.25M -$3.25M –
-Preferred Stock – – – – $0.00

Discussion

No comments yet — be the first to weigh in on ARQT.

Leave a comment

Scroll to Top